Aegros

Sustainability

Aegros' HaemaFrac® technology presents a transformative impact on sustainability in plasma fractionation, especially when compared to the traditional Cohn process and methanol-based methods. The sustainable advantages of HaemaFrac® lie in its gentler, more efficient design, which minimizes resource use, energy consumption, and chemical waste—issues that have plagued the Cohn process for decades.

Sustainability Challenges

Key Sustainability Issues with the Cohn Process and Methanol-Based Methods

The Cohn fractionation process, developed in the 1940s, relies heavily on cold ethanol as a fractionating agent, requiring precise control over temperature, pH, and ionic strength to separate proteins. This approach has significant sustainability drawbacks:

Environmental Impact

How HaemaFrac® Creates a Sustainable Advantage

Aegros’ HaemaFrac® technology addresses these challenges directly, with a process that is gentler, more resource-efficient, and substantially reduces the environmental impact associated with plasma fractionation.

Eco Advantage

Comparative Sustainability Impact

HaemaFrac® offers a stark contrast to the Cohn process in terms of sustainability:
HaemaFrac® sets a new sustainability benchmark in plasma fractionation by addressing the inefficiencies and environmental impacts of traditional methods like the Cohn process. Its elimination of hazardous chemicals, reduction in energy use, increase in product yield, and overall minimization of waste align HaemaFrac® with sustainable production principles that are critical in today’s biopharmaceutical industry. By adopting HaemaFrac®, companies not only gain operational efficiencies and cost savings but also contribute to a more environmentally responsible healthcare system. For investors, this technology represents a forward-looking investment in sustainability and a key step toward greener biomanufacturing.